Thomas P. Mathers is CEO at CoLucid Pharmaceuticals, Inc. (CLCD). They have made 6 open-market trades across 1 company since 2015, most recently 2017-03-01.
CIK 0001348649
1 open-market purchase totalling $53K since 2015, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLCD | 257,019 | $12.0M |
Shares reported on the most recent Form 4, priced at the 2017-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLCD | SELL · 10b5-1 | 2017-01-05 | 2017-01-05 | $34.78 | $52K | +39.9% | +40.4% | N/A |
| CLCD | SELL | 2016-12-05 | 2016-12-05 | $38.75 | $116K | -7.4% | -10.8% | N/A |
| CLCD | SELL · 10b5-1 | 2016-11-07 | 2016-11-07 | $28.57 | $43K | +29.4% | +37.0% | +60.3% |
| CLCD | SELL | 2016-10-05 | 2016-10-05 | $37.08 | $111K | -6.7% | -21.1% | -0.8% |
| CLCD | SELL | 2016-09-14 | 2016-09-16 | $23.32 | $140K | +21.0% | +18.1% | +28.4% |
| CLCD | SELL | 2016-09-06 | 2016-09-07 | $21.98 | $201K | +51.0% | +81.2% | +101.8% |
| CLCD | SELL | 2016-08-05 | 2016-08-05 | $8.31 | $12K | +17.3% | +221.6% | +293.5% |
| CLCD | SELL · 10b5-1 | 2016-07-05 | 2016-07-05 | $9.73 | $15K | +2.9% | -5.3% | +310.2% |
| CLCD | SELL · 10b5-1 | 2016-06-06 | 2016-06-07 | $7.25 | $11K | -3.6% | +25.3% | +231.0% |
| CLCD | BUY | 2015-08-25 | 2015-08-25 | $7.10 | $53K | -18.6% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.